Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × INDIV × Gemcitabine × Clear all

Phase

Status

Sponsor Class

OTHER 547 INDUSTRY 318 NIH 71 NETWORK 70 OTHER_GOV 14 UNKNOWN 1 INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Proflavine 3 Microbial Collagenase 2 sargramostim 1 pembrolizumab 1 pegfilgrastim 1 macimorelin 1 keyhole-limpet hemocyanin 1 Sodium Chloride 1 Sirolimus 1 Peptides 1 Monatide (IMS 3015) 1 Ipilimumab 1 Gemcitabine 1 Everolimus 1 Bimatoprost 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02429973 2015-04-29

GEIS-29

Broto, Javier Martín, M.D.

Phase 2 Completed

Osteosarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡